Illumina, Inc. and MyOme, a leading genomics innovation and risk modeling company, today announced a collaboration and investment by Illumina into MyOme. The collaboration and investment will help ...

Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP) Annual Meeting, held November 11-15, 2025 in Boston, MA. Key presentations at the conference highlighted ...

After more than 50 years of research, scientists still don't know exactly what causes autism. But the data make clear that ...

Cancer isn't just about broken genes-it's about broken architecture. Imagine a city where roads suddenly vanish, cutting off neighborhoods from essential services.

A noninvasive blood test to detect genetic material shed by tumors may help clinicians identify adverse events related to ...

Whether you turn red when drinking alcohol, dislike certain smells, or metabolize drugs differently from others, the ...

Analysis of more than 1 million people shows that mental-health disorders fall into five clusters, each of them linked to a ...

In a breakthrough study, scientists have discovered that a variant in one gene, GRIN2A, can directly cause mental illness – ...

In this video from the American Academy of Ophthalmology meeting, Jennifer I. Lim, MD, MBA, discusses three gene therapies currently being studied for the treatment of age-related macular degeneration ...

KAT is a suite of tools that analyse jellyfish hashes or sequence files (fasta or fastq) using kmer counts. The following tools are currently available in KAT: kmer: Produces a k-mer hash containing ...

The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of 8.81%. Key trends driving this growth include the emergence of liquid ...

A new study has developed a powerful computational method that can detect how genes interact with each other to influence ...